EP1294369 - NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.07.2006 Database last updated on 13.11.2024 | Most recent event Tooltip | 14.07.2006 | No opposition filed within time limit | published on 16.08.2006 [2006/33] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2003/13] | Inventor(s) | 01 /
Andersson, Mats J. Medicarb AB Annedalsvägen 37 S-168 65 Bromma / SE | 02 /
Andersson, Mattias AstraZeneca R & D Södertälje S-151 85 Södertälje / SE | 03 /
Eriksson, Patrik AstraZeneca R & D Södertälje S-151 85 Södertälje / SE | [2003/13] | Application number, filing date | 01934785.5 | 22.05.2001 | [2003/13] | WO2001SE01164 | Priority number, date | SE20000001916 | 23.05.2000 Original published format: SE 0001916 | [2003/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0189507 | Date: | 29.11.2001 | Language: | EN | [2001/48] | Type: | A1 Application with search report | No.: | EP1294369 | Date: | 26.03.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.11.2001 takes the place of the publication of the European patent application. | [2003/13] | Type: | B1 Patent specification | No.: | EP1294369 | Date: | 07.09.2005 | Language: | EN | [2005/36] | Search report(s) | International search report - published on: | SE | 29.11.2001 | Classification | IPC: | A61K31/15, A61K9/08 | [2003/13] | CPC: |
A61K9/08 (EP,US);
A61K31/15 (EP,KR,US);
A61K47/02 (EP,US);
A61K9/0019 (EP,US);
A61P25/00 (EP);
A61P25/28 (EP);
A61P39/06 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/13] | Extension states | AL | 23.12.2002 | LT | 23.12.2002 | LV | 23.12.2002 | MK | 23.12.2002 | RO | 23.12.2002 | SI | 23.12.2002 | Title | German: | NEUE FORMULIERUNGEN VON -G(A)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRON | [2003/13] | English: | NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE | [2003/13] | French: | NOUVELLES FORMULATIONS DE $g(a)-2,4-DISULFOPHENYLE-N-TERT-BUTYLNITRONE | [2003/13] | Entry into regional phase | 23.12.2002 | National basic fee paid | 23.12.2002 | Designation fee(s) paid | 23.12.2002 | Examination fee paid | Examination procedure | 20.11.2001 | Request for preliminary examination filed International Preliminary Examining Authority: SE | 23.12.2002 | Examination requested [2003/13] | 14.10.2003 | Despatch of a communication from the examining division (Time limit: M06) | 07.04.2004 | Reply to a communication from the examining division | 28.05.2004 | Communication of intention to grant the patent | 06.09.2004 | Fee for grant paid | 06.09.2004 | Fee for publishing/printing paid | Opposition(s) | 08.06.2006 | No opposition filed within time limit [2006/33] | Fees paid | Renewal fee | 02.06.2003 | Renewal fee patent year 03 | 01.06.2004 | Renewal fee patent year 04 | 31.05.2005 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US5780510 (CARNEY JOHN M [US]); | [A]US6107315 (CARNEY JOHN M [US], et al); | [Y] - MICHAEL E. AULTON, Pharmaceutics: The science of dosage form design, (1988), XP002948165 [Y] * page 368 - page 379 * |